Cabometyx
Cabometyx ingredients
| Active ingredient | Strength |
|---|---|
| Cabozantinib S-Malate | 20 mg/1, 40 mg/1, 60 mg/1 |
What Cabometyx is used for
The FDA lists the approved uses on the official label (below). In the EU, cabozantinib is approved as Cabometyx for:
Renal Cell Carcinoma (RCC) Cabometyx is indicated as monotherapy for advanced renal cell carcinoma as first-line treatment of adult patients with intermediate or poor risk, in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy. Cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. Hepatocellular carcinoma (HCC)Cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have previously been treated with sorafenib.Differentiated thyroid carcinoma (DTC)Cabometyx is indicated as monotherapy for the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma (DTC), refractory or not eligible to radioactive iodine (RAI) who have progressed during or after prior systemic therapy.Neuroendocrine Tumours (NET)Cabom…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Cabometyx
- Generic name
- Cabozantinib
- Made by
- Exelixis, Inc.
- Forms
- Tablet
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA208692
- On the US market since
- 2016
Official information
- Cabometyx prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Cabozantinib)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Cabometyx?
Cabometyx (Cabozantinib) is a cancer medicine made by Exelixis, Inc., approved by the US FDA.
What are the ingredients of Cabometyx?
Cabometyx contains Cabozantinib S-Malate (20 mg/1, 40 mg/1, 60 mg/1).
Is Cabometyx approved in Europe?
The same active substance is approved in the EU as Cabometyx.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA